Abstract

Pharmaceutical analysis plays a very prominent role in quality assurance as well as quality control of bulk drugs and pharmaceutical formulations. Rapid increase in pharmaceutical industries and production of drug in various parts of the world has brought a rise in demand for new analytical techniques in the pharmaceutical industries. As a consequence, analytical method development has become the basic activity of analysis. From the times of yore, people were trying to find safe and sound ways to treat viral infections. In the current scenario, due to the emerging of new viruses, the development of drugs for their treatment is also gaining equal importance. Before launching to the market, these drugs should undergo a validation process. High-performance liquid chromatography (HPLC) coupled with ultraviolet (UV), Photodiode array detectors (PDA), Mass spectrophotometer (MS) detectors etc. is one of the fastest, safe and precise technologies used for determination and separation of pharmaceutical drugs, impurities and biological samples. HPLC is versatile and it takes less time for quantification of drugs as compared to old liquid chromatography techniques. Tenofovir disoproxil fumarate (TDF), Emtricitabine (FTC) and Efavirenz (EFV) is antiretroviral medicine used treat AIDS as well as chronic Hepatitis-B. It is used alone or with other HIV medications to help control HIV infection. The present review article assesses the published analytical methods and a variety of approach for investigation of TDF, FTC and EFV in bulk drug as well as pharmaceutical formulations including combinations. The present studies revealed that HPLC technique along with the spectroscopic have been most widely explored for the analysis. The investigatory review may provide the comprehensive details to the researchers who are working in the area of analytical research of TDF, FTC and EFV.

Highlights

  • The main goal of the pharmaceutical industry is to provide drug products with sufficient quality, efficacy and safety

  • Antiretroviral therapy (ART) is strongly recommended for all HIV-infected individuals, regardless of pretreatment CD41 T cell count

  • The present review discussed about different analytical approach employed for the assessment of Tenofovir disoproxil fumarate (TDF), FTC and EFV

Read more

Summary

INTRODUCTION

The main goal of the pharmaceutical industry is to provide drug products with sufficient quality, efficacy and safety. Analytical methods allowing the determination of TDF, FTC and EFV drugs in various media, such as pharmaceutical formulations, biological matrices and environmental samples, is discussed. Treatment with EFV, FTC and TNF is the preferred first-line therapy for antiretroviral naïve HIV-1-infected persons [30]. EFV is a benzoxazin analogue approved by FDA in 1998 for the treatment of patients infected with HIV [57] It is an [4S]-6-chloro4-[2-cyclopropylethynyl]-4-[trifluoromethyl]-1H3,1benzoxazin-2-one and occurs as a white to slightly pink crystalline powder [58,59,60]. Various side effects are associated with high and low plasma levels of EFV in HIV-TB co-infected patients for which TDM studies become necessary. TNF, the form of tenofovir that is aborbed, has high aqueous solubility and low intestinal permeability and is classified as a Class 3 molecule [67, 68]. TNF melts within the range of 276-280 °C [71]

Spectrophotometric methods
Method
CONCLUSION
Findings
Global report
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.